Summary
Boston Scientific Corporation (BSX) filed an 8-K on May 1, 2015, to announce its upcoming Investor Day business review meeting scheduled for the same day. The meeting, hosted by CEO Mike Mahoney and other senior management, will include a webcast accessible on the company's Investor Relations website. This event is crucial for investors as it will provide insights into the company's performance, strategy, and future outlook. The company explicitly stated that the information furnished in this 8-K, including the presentation slides attached as Exhibit 99.1, is for informational purposes and is not deemed 'filed' under Section 18 of the Securities Exchange Act of 1934. This means the information will not be subject to the same liabilities as a formally filed document, but it still offers valuable content for understanding BSX's business directly from management.
Key Highlights
- 1Boston Scientific announced an Investor Day event for May 1, 2015, to provide a business review to the investment community.
- 2The event was scheduled to begin at 8:00 a.m. ET and would be hosted by CEO Mike Mahoney and other senior management.
- 3A webcast of the meeting and presentation slides were made available on the company's Investor Relations website.
- 4The filing includes Exhibit 99.1, which contains the presentation slides discussed during the Investor Day.
- 5Information furnished in this 8-K is for disclosure purposes and is not deemed 'filed' for Section 18 liability.
- 6This event serves as a key platform for management to communicate strategic updates and financial performance to investors.